Skip to main content
TipRanks
Go Ultimate75% OFF

Feedback (GZM0) AI Stock Analysis

0 Followers
DE:GZM0

Feedback

(Frankfurt:GZM0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Debt-free balance sheetThe absence of reported debt limits interest and refinancing burdens, preserving financial flexibility while the company develops its healthcare software. This gives management more room to allocate resources toward operations and product development without debt servicing further increasing cash pressure.
Negative Factors
Shrinking revenueConsecutive revenue declines indicate that the current business has not yet established a dependable growth trajectory. Shrinking scale makes it harder to absorb fixed operating costs, limits reinvestment capacity, and increases the challenge of converting the platform’s healthcare use case into sustainable expansion.

Feedback (GZM0) vs. iShares MSCI Germany ETF (EWG)

-75%-50%-25%0%25%50%75%100%DE:GZM0-63.22%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.56M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.4
Beta (1Y)
0.35
Revenue Growth
-14.68%
EPS Growth
70.53%
Country
Germany
Employees
26
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Feedback Business Overview & Revenue Model

Company Description

Feedback plc is a medical technology company, headquartered in London, UK, and established in 1958, that supplies specialized software and systems to individuals and organizations working within the medical imaging sector. Their product portfolio inc...

Feedback Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:GZM0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:KOOGB:KOO68NeutralGBP 67.37M11.2217.74%―-6.51%108.62%
GB:IXIGB:IXI55NeutralGBP 28.47M-6.50-16.18%―13.04%15.88%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:GDRGB:GDR49NeutralGBP 14.45M-0.82-1044.57%―65.60%74.84%
GB:COGGB:COG41NeutralGBP 15.65M-9.63-54.17%―11.86%23.81%
GB:OBDGB:OBD40UnderperformGBP 16.13M-0.29-451.74%―33.37%86.41%

* Healthcare Sector Average

Performance Comparison

-50%0%50%DE:GZM0GB:COGGB:GDRGB:IXIGB:OBDGB:KOODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:GZM0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:GZM0Feedback plc0.03-0.05-63.22%
GB:COGCambridge Cognition Holdings29.00-4.00-12.12%
GB:GDRGenedrive plc0.900.1113.92%
GB:IXIIXICO plc12.751.5013.33%
GB:OBDOxford BioDynamics0.12-0.17-58.93%
GB:KOOKooth Plc185.0057.5045.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.